SeleCT Connect

2021: Launch of the Light Air Leak Detection Software

In early August 2021, Olympus introduced SeleCT Connect software, which uses artificial intelligence for diagnostic imaging. This program allows you to automatically select patients with chronic obstructive pulmonary disease (COPD) and emphysema who are considered candidates for installation of the Spiral valve system.

SeleCT Connect is part of the KT Olympus SeleCT analytics package. More than 9,000 institutions will immediately access this software through the Nuance AI Marketplace cloud platform. health care USA It is known that Olympus worked with Nuance Communications, which it acquires, and Microsoft Imbio, a long-time partner in the development of analytical software, to create the SeleCT Connect program.

Olympus introduced software that detects air leakage from lungs

SeleCT Connect automatically sends the results of CT studies from the PACS archive to the QCT SeleCT analysis service. After analysis, the results are automatically returned to the medical history, where they can be viewed by the attending physician. The new service also allows you to send SeleCT analysis results to the health system's electronic health record (EHR), where they will also be available to the physician.

Connecting with Nuance's vast network of healthcare facilities helps physicians quickly and easily find suitable COPD patients to perform important intervention procedures, said Lynn Ray, international CEO and vice president of Olympus' respiratory systems division, in a July 27 press release. - Using automated workflows, our solution allows physicians to access detailed diagnostic data from Imbio AI imaging software. The program can quickly determine whether COPD patients can take advantage of our revolutionary development - the Spiral Valve valve system, which clinical studies have shown significantly improves the quality of life of emphysema patients.[1]

Notes